At Jeffrey Epstein’s Manhattan mansion in 2011, from left: James E. Staley, at the time a senior JPMorgan executive; former Treasury Secretary Lawrence Summers; Mr. Epstein; Bill Gates, Microsoft’s co-founder; and Boris Nikolic, who was the Bill and Melinda Gates Foundation’s science adviser.
Bill Gates and Jeffrey Epstein:
Bill Gates Met With Jeffrey Epstein Many Times, Despite His Past
Bill Gates made donations to MIT through Jeffrey Epstein —here are all of the tech mogul's connections to the financier
Engineer employed at Bill Gates' mansion 'traded 6,000 child porn images using Gmail account'
Jeffrey Epstein named Bill Gates' science adviser Boris Nikolic as an executor of his will, prompting the xenotransplantationist to express his shock - and turn down the offer
In 2003, Jeffrey Epstein established the Program for Evolutionary Dynamics at Harvard University which, over the past three years, collaborated with John Hopkins University to develop a database to predict the effect of drugs on the HIV virus and notably HIV resistance. Using data from thousands of blood tests on more than 20 anti-HIV drugs, the Program's model factors in different drug combinations and dosages, as well as blood type, viral genotype, viral load, HIV stage, treatment history, age, sex and a host of other variables to arrive at the most precisely engineered predictor of results for future patients.
Did Bill Gates Just Reveal the Reason Behind the Lock-Downs?
Rosemary Frei has an MSc in molecular biology from a faculty of medicine and was a freelance medical journalist for 22 years. She is now an independent investigative journalist in Canada. You can find her recent detailed investigative analysis of COVID here and follow her on Twitter.
On March 24 Bill Gates gave a highly revelatory 50-minute interview (above) to Chris Anderson. Anderson is the Curator of TED, the non-profit that runs the TED Talks.
The Gates interview is the second in a new series of daily ‘Ted Connects’ interviews focused on COVID-19.
Anderson asked Gates at 3:49 in the video of the interview – which is quickly climbing to three million views – about a ‘Perspective’ article by Gates that was published February 28 in the New England Journal of Medicine.
“You wrote that this could be the once-in-a-century pandemic that people have been fearing. Is that how you think of it, still?” queried Anderson.
“Well, it’s awful to say this but, we could have a respiratory virus whose case fatality rate was even higher. If this was something like smallpox, that kills 30 percent of people. So this is horrific,” responded Gates.
“But, in fact, most people even who get the COVID disease are able to survive. So in that, it’s quite infectious – way more infectious than MERS [Middle East Respiratory Syndrome] or SARS [Severe Acute Respiratory Syndrome] were. [But] it’s not as fatal as they were. And yet the disruption we’re seeing in order to knock it down is really completely unprecedented.”
Gates reiterates the dire consequences for the global economy later in the interview.
“We need a clear message about that,” Gates said starting at 26:52.
“It is really tragic that the economic effects of this are very dramatic. I mean, nothing like this has ever happened to the economy in our lifetimes. But … bringing the economy back and doing [sic] money, that’s more of a reversible thing than bringing people back to life. So we’re going to take the pain in the economic dimension, huge pain, in order to minimize the pain in disease and death dimension.”
However, this goes directly against the imperative to balance the benefits and costs of the screening, testing and treatment measures for each ailment – as successfully promulgated for years by, for example, the Choosing Wisely campaign – to provide the maximum benefit to individual patients and society as a whole.
Even more importantly, as noted in an April 1 article in OffGuardian, there may be dramatically more deaths from the economic breakdown than from COVID-19 itself.
“By all accounts, the impact of the response will be great, far-reaching, and long-lasting,”
Kevin Ryan wrote in the article. Ryan estimated that well over two million people will likely die from the sequelae of the lock-downs and other drastic measures to enforce ‘social distancing.’
Millions could potentially die from suicide, drug abuse, lack of medical coverage or treatment, poverty and lack of food access, on top of other predictable social, medical and public-health problems stemming from the response to COVID-19.
Gates and Anderson did not touch on any of those sequelae. Instead, they focused on rapidly ramping up testing and medical interventions for COVID-19.
Gates said at 30:29 in the interview that he and a large team are moving fast to test anti-virals, vaccines and other therapeutics and to bring them to market as quickly as possible.The Gates Foundation and Wellcome Trust with support from Mastercard and now others, created this therapeutic accelerator to really triage out [candidate therapeutics]…You have hundreds of people showing up and saying, ‘Try this, try that.’ So we look at lab assays, animal models, and so we understand which things should be prioritized for these very quick human trials that need to be done all over the world.”
The accelerator was launched March 10 with approximately $125 million in seed funding. Three days later Gates left Microsoft.
Not long before that, on January 23, Gates’s organization the Coalition for Epidemic Preparedness Innovations (CEPI) announced it will fund three programs to develop COVID-19 vaccines. These are the advancing of DNA-vaccine candidates against MERS and Lassa fever, the development of a “‘molecular clamp’ platform” that “enables targeted and rapid vaccine production against multiple viral pathogens,” and the manufacture and Phase 1 clinical study of an mRNA vaccine against COVID.
“The programmes will leverage rapid response platforms already supported by CEPI as well as a new partnership. The aim is to advance nCoV-2019 vaccine candidates into clinical testing as quickly as possible,” according to a news release.
Then at 32:50 in the video, Anderson asked whether the blood serum from people who have recovered from a COVID infection can be used to treat others.“I heard you mention that one possibility might be treatments from the serum, the blood serum of people who had had the disease and then recovered. So I guess they’re carrying antibodies,” said Anderson. “Talk a bit about that and how that could work and what it would take to accelerate that.”
[Note that Anderson did not ask Gates about, instead, just letting most of the population – aside from people most vulnerable to serious illness from the infection, who should be quarantined — be exposed to COVID-19 and as a result very likely recover and develop life-long immunity. As at least one expert has observed, “as much as ninety-nine percent of active cases [of COVID-19] in the general population are ‘mild’ and do not require specific medical treatment” to recover.]
“This has always been discussed as, ‘How could you pull that off?’” replied Gates. “So people who are recovered, it appears, have very effective antibodies in their blood. So you could go, transfuse them and only take out white cells, the immune cells.”
However, Gates continued, he and his colleagues have dismissed that possibility because it’s “fairly complicated – compared to a drug we can make in high volume, you know, the cost of taking it out and putting it back in probably doesn’t scale as well.”
Then a few seconds later, at 33:45, Gates drops another bomb:We don’t want to have a lot of recovered people […] To be clear, we’re trying – through the shut-down in the United States – to not get to one percent of the population infected. We’re well below that today, but with exponentiation, you could get past that three million [people or approximately one percent of the U.S. population being infected with COVID-19 and the vast majority recovering]. I believe we will be able to avoid that with having this economic pain.”
It appears that rather than let the population be exposed to the virus and most develop antibodies that give them natural, long-lasting immunity to COVID-19, Gates and his colleagues far prefer to create a vast, hugely expensive, new system of manufacturing and selling billions of test kits, and in parallel very quickly developing and selling billions of antivirals and vaccines.
And then, when the virus comes back again a few months later and most of the population is unexposed and therefore vulnerable, selling billions more test kits and medical interventions.
Right after that, at 34:14, Gates talked about how he sees things rolling out from there.Eventually what we’ll have to have is certificates of who’s a recovered person, who’s a vaccinated person […] Because you don’t want people moving around the world where you’ll have some countries that won’t have it under control, sadly. You don’t want to completely block off the ability for people to go there and come back and move around. So eventually there will be this digital immunity proof that will help facilitate the global reopening up.”
[Sometime on the afternoon of March 31 the last sentence of this quote was edited out of the official TED video of the interview. Fortunately, recordings of the complete interview are archived elsewhere.]
In the October 2019 Event 201 novel-corona virus-pandemic simulation co-sponsored by the Bill & Melinda Gates Foundation, the World Economic Forum and a division of the Johns Hopkins Bloomberg School of Public Health, a poll that was part of the simulation said that 65% of people in the U.S. would be eager to take a vaccine for COVID-19, “even if it’s experimental.”
This will be tremendously lucrative.
Vaccines are very big business: this Feb. 23 CNBC article, for example, describes the vaccine market as six times bigger than it was 20 years ago, at more than $35 billion annually today, and providing a $44 return for every $1 invested in the world’s 94 lowest-income countries.
Notably, the Bill & Melinda Gates Foundation – which has an endowment of $52 billion – has given more than $2.4 billion to the World Health Organization (WHO) since 2000, according to a 2017 Politico article. (While over the same time frame countries have reduced their contributions to the world body, particularly after the 2008-2009 depression, and now account for less than one-quarter of the WHO’s budget.) The WHO is now coordinating approximately 50 groups around the world that are working on candidate vaccines against COVID-19.
The Politico article quotes a Geneva-based NGO representative as saying Gates is “treated liked a head of state, not only at the WHO, but also at the G20,” and that Gates is one of the most influential people in global health.
Meanwhile, officials around the world are doing their part to make sure everyone social distances, self-isolates and/or stays locked down.
For example, here’s Toronto’s Medical Officer of Health, Dr. Eileen de Villa, at her and Toronto Mayor John Tory’s March 30 press briefing:“We find ourselves in the midst of a global pandemic. We should expect some more people will get sick – and for some, sadly, will die. This is why it is so important to stay at home to reduce virus spread. And to protect front-line workers, healthcare workers and our essential workers, so they can continue to protect us. People shouldn’t have to die, people shouldn’t have to risk death taking care of us because others won’t practice social distancing or physical distancing.”
Yet look how close Ontario’s Chief Medical Officer of Health, Dr. David Williams, is sitting to Haley Chazan, Senior Manager, Media Relations, for Christine Elliott, Deputy Premier and Minister of Health of Ontario.
This was on Friday, March 27, just before the start of that day’s daily press conference by Dr. Williams and Ontario’s Associate Medical Officer of Health Dr. Barbara Yaffe:
They were sitting two seats, or just a couple of feet, apart. A short time later Chazan got up and stood even closer to Dr. Williams for a little while:
Dr. Williams and Chazan do not live together. Rather, Dr. Williams very likely knows – just as Gates knows – that there is little if any reason to worry about being in close contact with other people unless you or they are vulnerable to developing a severe illness from COVID-19. He surely knows, also, that if you contract COVID-19 and you’re otherwise healthy you’ll very likely have few symptoms, if any, and recover quickly. And that this exposure in fact is beneficial because in the process you will develop antibodies to the virus and have natural, long-lasting immunity to it.
Yet in the March 27 press conference, just like all the others he has participated in during the COVID-19 crisis, Dr. Williams lectured the public about maintaining social distancing. He told people not to go outside on the coming weekend to enjoy the nice weather because, otherwise, they might walk past someone and not be two metres apart.
Dr. Williams is among the large cadre of powerful officials who’ve crashed the global economy by forcing tens of millions of small- and medium-sized businesses to close in the name of the need for forced, severe, social distancing and lock-downs.
They’ve shattered society, suspended most civil liberties and prohibited most activities and connections that keep people mentally and physically healthy. At the same time the officials have prioritized COVID-19 care over everything else and, as a result, severely limited billions of people’s access to life-saving healthcare services ranging from acquiring medication and blood transfusions to having organ transplants and cancer surgeries.
Nature | News
Calls in India for legal action against US charity
Study organizers firmly refute alleged misconduct in cervical cancer vaccination project.
& Declan Butler
09 September 2013
Rights & Permissions
Twenty-three thousand girls were administered with the human papillomavirus vaccines to assess distribution in India.
An Indian parliamentary committee has recommended legal action against a major US-based NGO that it accuses of violating ethical standards and national law during a study to assess the possibility of launching a cervical cancer vaccination programme in the country.
The Parliamentary Standing Committee on Health and Family Welfare said that the Program for Appropriate Technology in Health (PATH), a non-profit organization based in Seattle, Washington, and several Indian institutions, failed to follow proper procedures, adequately monitor events or obtain informed consent from all participants.
It called the field test of two human papilloma virus (HPV) vaccines, stopped after seven vaccinated children died, “very intriguing and fishy”, and asserted, without evidence, that the goal was to generate profits for the pharmaceutical industry.
Vaccine campaign to target deadly childhood diarrhoea
Vaccine trial's ethics criticized
The charges were firmly rebutted by PATH, with Vivien Tsu, the director of its cervical-cancer prevention project, arguing that the report is “inaccurate in many details and incorrectly implies violations of approved practices”. “PATH is committed to meeting the highest scientific, ethical, and legal standards in our work,” she says.
After breast cancer, cervical cancer caused by HPV is the second most common cancer in women worldwide, with around 500,000 new cases and some 250,000 deaths each year — including an estimated 134,000 new cases and 73,000 deaths in India.
The first HPV vaccine, Gardasil, was approved by the US Food and Drug Administration (FDA) in 2006. Two years later, India approved that drug, which is made by Merck, based in Whitehouse Station, New Jersey, as well as Cervarix, another HPV vaccine, made by GlaxoSmithKline, based in London. Both vaccines had been approved for use by the US Food and Drug Administration before the PATH project began in 2009. The study, which used donations of these vaccines and was funded by the Bill and Melinda Gates Foundation, aimed to gather evidence as to how an HPV vaccine might best be widely introduced within the Indian health-care system.
It involved vaccinating 13,000 girls aged 10–14 in the state of Andhra Pradesh with Gardasil and 10,000 with Cervarix in Gujarat, and analysed, for example, how to raise community awareness of HPV, and whether delivering vaccines was best achieved at schools or in health centres.
The study was initially intended to run until 2011, but the Indian government halted the trials in March 2010 after activist groups opposed to the introduction of the vaccine in India alleged safety and ethical violations following the death of seven girls enrolled in the study. An internal government inquiry concluded in 2011 that the deaths were unrelated to the vaccination and that no ethical norms had been infringed.
But the standing committee’s report to the Indian parliament, released on 30 August, maintains that the study violated ethical norms and India’s laws and regulations. As well as PATH, the state governments of Andhra Pradesh and Gujarat and the Indian Council of Medical Research (ICMR) were also singled out for criticism.
The report argues that the study should have fallen under clinical-trials legislation despite its designation as a demonstration project, that informed consent was not properly obtained from all study participants — many of whom were illiterate — and that adverse events were not adequately monitored or reported.
Tsu says that the study, whose primary goal was to determine how many girls were vaccinated, was in no way a clinical trial and that no clinical outcomes were measured — the project had been delayed to await the vaccines’ approval in India in 2008, she adds. Proper procedures for seeking informed consent and tracking adverse events were also used, she says. In a statement on its website, PATH said: “We strongly disagree with the findings, conclusions and tone of the released report and its disregard of the evidence and facts.”
PATH has similar research programmes in Vietnam, Uganda and Peru as part of a project — begun in 2006 with a US$27.8-million grant from the Bill and Melinda Gates Foundation — that aimed to provide poorer countries with practical data on the feasibility and acceptability of introducing the vaccine, notes Tsu.
This year, the GAVI Alliance, a multibillion-dollar public–private partnership that funds and delivers vaccines to developing countries, began introducing HPV vaccines in eight African countries, and aims to vaccinate 30 million girls in 40 nations by 2020. PATH’s demonstration projects in Peru and Uganda helped to launch national HPV immunization programmes and contributed to the GAVI Alliance’s decision to subsidize HPV vaccines for the world’s poorest countries.
December 06th, 2019
By Alan Macleod
If Gates represents a net negative force in world politics, why does he receive such good press? One reason may be his sizeable donations to a host of mainstream corporate media outlets. For example, the Gates Foundation underwrites the entire Global Development section of the Guardian, and has given the British newspaper over $9 million. Studying its donation database, it transpires it has also contributed over $3 million to NBC Universal, over $4 million to the influential French newspaper, Le Monde, over $4.5 million to NPR, $1 million to Al-Jazeera, and an astonishing $49 million to the BBC’s Media Action program, to name only a few. He who pays the piper, it is said, calls the tune. McGoey claims that the motive of billionaires giving to media organizations is primarily “to help legitimate the spurious idea that large corporate actors can rectify the economic harms and economic inequality that their practices have often compounded.”
Gates himself is the head of a gigantic media empire. We already rely on Microsoft for social media (LinkedIn), entertainment (Xbox), hardware and software like the Windows Phone and Windows OS. The company also owns stakes in media giants like Comcast and AT&T. And the “MS” in “MSNBC” stands for “Microsoft.”
Video doesn't work anymore
Users browsing this forum: Google [Bot] and 6 guests